Contributions to collective works (2)
Peer-reviewed journal articles (257)
1.
Lavis, P., Pingitore, J., Doumont, G., Garabet, A., Van Simaeys, G., Lacroix, S., Passon, N., Van Heymbeek, C., De Maeseneire, C., Allard, J., Collin, A., Huaux, F., Decaestecker, C., Salmon, I., Goldman, S., Cardozo, A. K., & Bondue, B. (2023). Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis. Respiratory research, 24(1), 254. doi:10.1186/s12931-023-02556-62.
Cassier, P. A., Navaridas, R., Bellina, M., Rama, N., Ducarouge, B., Hernandez-Vargas, H., Delord, J. P., Lengrand, J., Paradisi, A., Fattet, L., Garin, G., Gheit, H., Dalban, C., Pastushenko, I., Neves, D., Jelin, R., Gadot, N., Braissand, N., Léon, S., Degletagne, C., Matias-Guiu, X., Devouassoux-Shisheboran, M., Mery-Lamarche, E., Allard, J., Zindy, E., Decaestecker, C., Salmon, I., Perol, D., Dolcet, X., Ray-Coquard, I., Blanpain, C., Bernet, A., & Mehlen, P. (2023). Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer. Nature (London). doi:10.1038/s41586-023-06367-z3.
Lengrand, J., Pastushenko, I., Vanuytven, S., Song, Y., Venet, D., Sarate, R. M., Bellina, M., Moers, V., Boinet, A., Sifrim, A., Rama, N., Ducarouge, B., Van Herck, J., Dubois, C., Scozzaro, S., Lemaire, S., Gieskes, S., Bonni, S., Collin, A., Braissand, N., Allard, J., Zindy, E., Decaestecker, C., Sotiriou, C., Salmon, I., Mehlen, P., Voet, T., Bernet, A., & Blanpain, C. (2023). Pharmacological targeting of netrin-1 inhibits EMT in cancer. Nature (London). doi:10.1038/s41586-023-06372-24.
Racu, M.-L., Bernardi, D., Chaouche, A., Zindy, E., Navez, J., Loi, P., Maris, C., Closset, J., Van Laethem, J.-L., Decaestecker, C., Salmon, I., & D'Haene, N. (2023). SMAD4 Positive Pancreatic Ductal Adenocarcinomas Are Associated with Better Outcomes in Patients Receiving FOLFIRINOX-Based Neoadjuvant Therapy. Cancers (Basel), 15(15). doi:10.3390/cancers151537656.
Lebrun, L., Absil, L., Remmelink, M., De Mendonça, R., D'Haene, N., Gaspard, N., Rusu, S., Racu, M.-L., Collin, A., Allard, J., Zindy, E., Schiavo, A. A., De Clercq, S., De Witte, O., Decaestecker, C., Lopes, M. B., & Salmon, I. (2023). SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature. Acta neuropathologica communications, 11(78). doi:10.1186/s40478-023-01566-18.
Catteau, X., Zindy, E., Bouri, S., Noël, J. C., Salmon, I., & Decaestecker, C. (2023). Comparison Between Manual and Automated Assessment of Ki-67 in Breast Carcinoma: Test of a Simple Method in Daily Practice. Technology in cancer research & treatment, 22, 15330338231169603. doi:10.1177/1533033823116960310.
Lavis, P., Morra, S., Orte Cano, C., Albayrak, N., Corbiere, V., Olislagers, V., Dauby, N., Del Marmol, V., Marchant, A., Decaestecker, C., Mascart, F., De Vos, N., Van De Borne, P., Salmon, I., Remmelink, M., Parmentier, M., Cardozo, A. K., & Bondue, B. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in immunology, 13, 941663. doi:10.3389/fimmu.2022.94166311.
Martens, C., Rovai, A., Bonatto, D., Metens, T., Debeir, O., Decaestecker, C., Goldman, S., & Van Simaeys, G. (2022). Deep Learning for Reaction-Diffusion Glioma Growth Modeling: Towards a Fully Personalized Model? Cancers (Basel), 14(10), 2530. doi:10.3390/cancers1410253013.
Racu, M.-L., Lebrun, L., Schiavo, A. A., Van Campenhout, C., De Clercq, S., Absil, L., Minguijon Perez, E., Maris, C., Decaestecker, C., Salmon, I., & D'Haene, N. (2022). The Role of SMAD4 Inactivation in Epithelial-Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link? Cancers (Basel), 14(4). doi:10.3390/cancers1404097314.
Rusu, S., Verocq, C., Trepant, A.-L., Maris, C., De Nève, N., Blanchard, O., Van Campenhout, C., De Clercq, S., Rorive, S., Cotoi, O. S., Decaestecker, C., Salmon, I., & D'Haene, N. (2021). Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma. Molecular and clinical oncology, 15(6), 270. doi:10.3892/mco.2021.243215.
Martens, C., Lebrun, L., Decaestecker, C., Vandamme, T., Van Eycke, Y.-R., Rovai, A., Metens, T., Debeir, O., Goldman, S., Salmon, I., & Van Simaeys, G. (2021). Initial Condition Assessment for Reaction-Diffusion Glioma Growth Models: A Translational MRI-Histology (In)Validation Study. Tomography, 7(4), 650-674. doi:10.3390/tomography704005516.
Lebrun, L., Bizet, M., Melendez Asensio, B., Alexiou, B., Absil, L., Van Campenhout, C., D'Haene, N., Rorive, S., Fuks, F., Decaestecker, C., & Salmon, I. (2021). Analyses of DNA Methylation Profiling in the Diagnosis of Intramedullary Astrocytomas. Journal of neuropathology and experimental neurology, 80(7), 663-673. doi:10.1093/jnen/nlab05217.
Martens, C., Debeir, O., Decaestecker, C., Metens, T., Lebrun, L., Leurquin-Sterk, G., Trotta, N., Goldman, S., & Van Simaeys, G. (2021). Voxelwise principal component analysis of dynamic [s-methyl-11 c]methionine pet data in glioma patients. Cancers (Basel), 13(10), 2342. doi:10.3390/cancers13102342